Press release
Market Trend Insights: The Impact of Recent Advances on the Peptide Therapeutics Market
Peptide Therapeutics
Projected Market Size and Expansion of the Peptide Therapeutics Market
The peptide therapeutics market is forecasted to grow rapidly, reaching a valuation of $74.98 billion by 2029. This impressive growth corresponds to a compound annual growth rate (CAGR) of 11.1%. Several factors are propelling this surge, including the heightened demand for personalized medical treatments, broader applications in immunotherapy, improvements in peptide delivery technologies, discovery of new peptide targets for infectious diseases, and an increased focus on rare diseases. Additionally, the market is shaped by trends such as technological progress in peptide synthesis, growing investment activities, prioritization of drug safety, expansion into emerging markets, and integration of artificial intelligence (AI) in various stages of development.
Download a free sample of the peptide therapeutics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp
Key Factors Behind the Rising Demand for Peptide Therapeutics
One major driver fueling the market is the growing interest in personalized medicine, which tailors treatments to individual patient profiles, enhancing effectiveness and reducing side effects. Peptides offer unique advantages that align well with this approach, making them valuable tools in precision healthcare.
Another important factor is the expanding use of peptide-based therapies in immunotherapy, which is becoming a cornerstone of modern treatment strategies for cancer and autoimmune diseases. Advances in delivery systems also contribute by improving the stability and bioavailability of peptides, thereby increasing their therapeutic potential.
Leading Companies Making an Impact in the Peptide Therapeutics Market
The peptide therapeutics market features several prominent players, including Pfizer Inc., Johnson & Johnson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., and Merck & Co Inc.
View the full peptide therapeutics market report:
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
Significant Acquisition Highlighting Market Consolidation
In July 2024, AstraZeneca plc, a pharmaceutical and biotechnology leader based in England, acquired France-based Amolyt Pharma for $1.05 billion. Amolyt Pharma specializes in clinical-stage development of therapeutic peptides targeting rare endocrine and metabolic disorders. This acquisition supports AstraZeneca's strategic goals to bolster its rare disease portfolio and expand its therapeutic reach in critical areas of unmet medical need.
Innovations Fueling the Peptide Therapeutics Market
Companies in this field are focusing on introducing advanced technologies such as cell culture processes to enhance their competitive positioning. Cell culture involves growing cells in controlled environments outside the body, which is essential for developing biological drugs.
For example, Evonik Industries AG, a German specialty chemicals company, launched cQrex KC in June 2023. This next-generation peptide is designed to improve cell culture processes used in biopharmaceutical manufacturing. It optimizes cystine supply, boosting productivity in vaccine production, viral vectors, and cell therapies, thereby supporting innovation in peptide-based drug development.
Detailed Segmentation of the Peptide Therapeutics Market
The market is organized into several key segments:
1) By Type: Generic and Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, and Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous System disorders, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, and Other Applications
Further distinctions within these categories include:
- Generic Peptides: Generic Peptide Drugs and Biosimilars
- Branded Peptides: Innovative Peptide Drugs and Patent-Protected Peptides
This structured segmentation allows for a comprehensive understanding of the market's composition and potential growth avenues.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Market Trend Insights: The Impact of Recent Advances on the Peptide Therapeutics Market here
News-ID: 4318914 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Peptide
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg
Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity.
This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
